SI-BONE, Inc. (SIBN) Stock

Healthcare · Medical Devices · Member of Other US Stocks

SI-BONE, Inc. (SIBN) closed at USD 19.47 on 2026-10-14, a change of +23.3 % over the past year, with a market capitalization of USD 882.99M.

SI-BONE, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

SI-BONE, Inc. key figures

Previous close

USD 19.47 (2026-10-14)

1-year change

+23.3 %

Market cap

USD 882.99M

Enterprise value

USD 789.19M

P/E ratio (trailing)

-58.56

P/E ratio (forward)

-60.18

EPS (trailing)

-0.34

EPS (forward)

-0.33

PEG ratio

n/a

Price to book

4.88

Revenue growth

15.2 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

9.01

Employees

376

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About SI-BONE, Inc.

SI-BONE, Inc., a medical device company, develops procedural solutions for compromised bone, grounded in expertise in biomechanical design and anatomy-specific applications in the United States and internationally. It offers a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products. The company also provides IFUSE, a triangular titanium implant with a triangular cross-section and porous surface that stabilizes the joint and facilitates the biological fixation of the bone onto the implant to drive fusion; IFUSE 3D, a triangular titanium implant with a porous surface and fenestrated design to self-harvest bone; IFUSE BONE, which supports and augments the patient's own bone tissue in orthopedic procedures; IFUSE TORQ, an additively-manufactured threaded implant designed to allow for osteointegration, or incorporation of the bone into the implant's porous surface and structure; IFUSE BEDROCK GRANITE, an implant with a machined titanium core and a tulip that attaches to the rod and provides fusion and fixation to the sacroiliac joint as a foundational element for segmental spinal fusion; and IFUSE TORQ TNT, a porous threaded design with lengths capable of spanning the posterior pelvis, passing through the ipsilateral ilium, sacrum, and through the contralateral ilium. The company markets its products primarily with a direct sales force, as well as through third-party sales agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for SI-BONE, Inc. and compare it with other stocks.